Literature DB >> 20654299

Effects of acute and chronic arsenic exposure of human-derived keratinocytes in an In Vitro human skin equivalent system: a novel model of human arsenicism.

W T Klimecki1, A H Borchers, R E Egbert, R B Nagle, D E Carter, G T Bowden.   

Abstract

An organotypic culture (OTC) of a human keratinocyte cell line (HaCaT) over a human fibroblast-embedded collagen gel was used to model human epidermis in arsenicism, a syndrome that currently lacks valid experimental models. Keratinocytes were exposed acutely or chronically to a mixture of arsenate (0.5 muM), monomethylarsonic acid (MMA; 0.5 muM) and dimethylarsinic acid (DMA; 1.5 muM), or to the individual components of the mixture. OTCs were assayed for microscopic morphology, the proliferating cell marker, Ki-67, labelling and cytokeratin expression. Acute exposures resulted in an epidermal phenotype that accurately modelled early human lesions, including hyperkeratosis, acanthosis and keratin 16 induction. Chronic exposures resulted in a de-differentiated epidermal phenotype with focal nests of keratinocytes growing into the collagen gel. The keratin 8 18 pair was induced by either acute or chronic arsenic exposure, as was the proliferating cell marker, Ki-67. Exposure of keratinocytes to individual arsenic compounds demonstrated that all arsenic mixture-induced changes could be duplicated by exposure to arsenate alone. In contrast, MMA and DMA were inactive. This study establishes OTC as a useful model of arsenicism, and implicates inorganic arsenic as the ultimate carcinogen.

Entities:  

Year:  1997        PMID: 20654299     DOI: 10.1016/s0887-2333(97)00006-4

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  7 in total

1.  Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway.

Authors:  Horacio Gonzalez; Carolina Lema; Robert A Kirken; Rosa A Maldonado; Armando Varela-Ramirez; Renato J Aguilera
Journal:  Clin Cancer Drugs       Date:  2015

2.  Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction?

Authors:  Mercedes Meza; A Jay Gandolfi; Walter T Klimecki
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-23       Impact factor: 4.219

Review 3.  Arsenic carcinogenicity: relevance of c-Src activation.

Authors:  Petia P Simeonova; Michael I Luster
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

4.  Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.

Authors:  D R Germolec; J Spalding; H S Yu; G S Chen; P P Simeonova; M C Humble; A Bruccoleri; G A Boorman; J F Foley; T Yoshida; M I Luster
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

5.  Expression of laminin 5-γ2 chain in cutaneous squamous cell carcinoma and its role in tumour invasion.

Authors:  H Hamasaki; K Koga; M Aoki; M Hamasaki; N Koshikawa; M Seiki; H Iwasaki; J Nakayama; K Nabeshima
Journal:  Br J Cancer       Date:  2011-08-09       Impact factor: 7.640

6.  Disruption of Skin Stem Cell Homeostasis following Transplacental Arsenicosis; Alleviation by Combined Intake of Selenium and Curcumin.

Authors:  Shiv Poojan; Sushil Kumar; Vikas Verma; Anupam Dhasmana; Mohtashim Lohani; Mukesh K Verma
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

7.  Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements.

Authors:  R Weinmuellner; K Kryeziu; B Zbiral; K Tav; B Schoenhacker-Alte; D Groza; L Wimmer; M Schosserer; F Nagelreiter; S Rösinger; M Mildner; E Tschachler; M Grusch; J Grillari; P Heffeter
Journal:  Arch Toxicol       Date:  2017-08-03       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.